Skip to main content

Morning Bell 13 January

Jessica Amir
January 13, 2021

The ASX200 is eyeing a fall of 0.1% at the open. The expected pull back comes as Aussie scientists are calling for the AstraZeneca vaccine rollout to be paused given it’s only 62% effective. The Aussie Government pre-bought 54 million doses of the AstraZeneca vaccine, however Scientists say they prefer the Pfizer and Moderna vaccines as they are 95% effective.

Broad market sentiment remains high with the economy expected to recover this year, as a vaccine is said to be available in Australia as early as February.

What to watch today:

  • Oil gained 1.7% overnight rising to a new 11-month high of US$53.17.
  • Lithium stocks as the lithium price is clawing out of a 2-year bear market.

Local trading ideas:

  • Citi increased Afterpay’s (ASX:APT) price target to $115 but maintained the stock as a hold, noting app downloads somewhat slowed in December.
  • UBS reiterated CSL (ASX:CSL) as a buy with a $346 target. 21 blood-plasma collection centres have opened since July last year and UBS thinks CSL is on track to reach its FY21 target opening 20-30 centres as vaccine rollouts continue.
  • Super Retail Group (ASX:SUL) was upgraded to a buy from a hold by UBS.
  • ARB Corp (ASX:ARB), Race Oncology (ASX:RAC) and Think Childcare (ASX:TNK) are giving off strong bullish charting signals according to Trading Central.

Market Update 14 March 2016

Julia Lee
March 14, 2016

Bell Potter banks march

Bell Direct
March 11, 2016

Portfolio Strategy Builder

Bell Direct
March 7, 2016

Technical Insights Tutorial

Bell Direct
March 7, 2016

Daily Trading Idea Tutorial

Bell Direct
March 7, 2016

Market Insights 26 Feb

Julia Lee
February 26, 2016

Small Cap CEO Interview: Ahalife

Bell Direct
February 24, 2016

Bell Potter: Hybrid stocks

Bell Direct
January 28, 2016

Bell Potter outlook: resources

Bell Direct
January 26, 2016

Richard Hemming: small cap dividend stocks

Richard Hemming
January 22, 2016